Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine

Abstract

This study establishes FlaB as a successful fusion partner for recombinant subunit tetanus vaccine applicable through mucosal route, and it further endorses our previous observations that FlaB could be a stable adjuvant partner for mucosal vaccines.